Additionally, the plasma concentration of nesfatin-1 in patients with acute myocardial infarction (AMI) was lower than in the control group, which showed nesfatin-1 to be a protective agent against AMI [36]. This evidence concerns the gene NUCB2 and myocardial infarction.